| 000 | 01943cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030212.0 | ||
| 008 | 100315s2009 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.04.M.Sc.2009.Mo.A | ||
| 100 | 0 | _aMohammed Shafiq Awad | |
| 245 | 1 | 0 |
_aAsymmetric dimethyl 1- arginine endogenous inhibitor of nitric oxide synthase in congestive heart failure : _bRelation to cardiac function / _cMohammed Shafiq Awad ; Supervised Magdy Abdelhamid , Yasser Ahmed Abdelhady |
| 246 | 1 | 5 | _aداى ميثيل - ال -ارجينين الغير متماثل كمثبط داخلى لاكسيد النيتريك فى مرضى هبوط عضلة القلب وعلاقتة بوظائف القلب |
| 260 |
_aCairo : _bMohammed Shafiq Awad , _c2009 |
||
| 300 |
_a155P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Cardiology | ||
| 520 | _aNitric oxide and its endogenous inhibitor Asymmetric dimethyl -l - arginine both are increased in the heart failure milieu and are related to pathophysiogy of systolic impairment and endothelial dysfunction . To evaluate the levels of nitric oxide metabolites (NOx ) (as indirect evidence of nitric oxide level ) and the level of ADMA in patients with moderate to severe congestive heart failure both ischemic and idiopathic etiologies find any etiology - specific difference and test their relations to EF and endothelial function as measured by FMD | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aADMA | |
| 653 | 4 | _aHeart Failure | |
| 653 | 4 | _aNitric oxide | |
| 700 | 0 |
_aMagdy Abdelhamid , _eSupervisor |
|
| 700 | 0 |
_aYasser Ahmed Abdelhady , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c29744 _d29744 |
||